Literature DB >> 6601460

Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography.

E M Geltman, J L Smith, D Beecher, P A Ludbrook, M M Ter-Pogossian, B E Sobel.   

Abstract

The present study was performed to determine whether positron emission tomography performed after intravenous injection of 11C-palmitate permits detection and characterization of congestive cardiomyopathy. Positron emission tomography was performed after the intravenous injection of 11C-palmitate in 13 normal subjects, 17 patients with congestive cardiomyopathy, and six patients with initial transmural myocardial infarction (defined electrocardiographically). Regionally depressed accumulation of 11C-palmitate was assessed, characterized, and quantified in seven parallel transaxial reconstructions in each patient. Normal subjects exhibited homogeneous accumulation of 11C-palmitate within the left ventricular myocardium, with smooth transitions in regional content of radioactivity. Patients with cardiomyopathy exhibited marked spatial heterogeneity of the accumulation of palmitate throughout the myocardium, easily distinguishable from that in normal subjects and distinct from that observed in patients with transmural infarction, in whom discrete regions of depressed accumulation of palmitate were observed with residual viable myocardium accumulating palmitate homogeneously. Patients with cardiomyopathy exhibited a larger number of discrete noncontiguous regions of accumulation of palmitate within the myocardium than either control subjects or patients with transmural infarction (17.4 +/- 0.6 [SEM] versus 11.8 +/- 0.7 versus 10.3 +/- 0.6, p less than 0.005). Similarly, regions of accumulation of palmitate were irregularly shaped in patients with cardiomyopathy, with a longer normalized perimeter than either control subjects or patients with transmural infarction (2.0 +/- 0.05 versus 1.8 +/- 0.06 versus 1.9 +/- 0.09, p less than 0.05). Regional abnormalities of the accumulation of 11C-palmitate could not be explained by regional differences in left ventricular wall motion or myocardial perfusion. Thus, marked heterogeneity of regional myocardial accumulation of 11C-palmitate is detectable and quantifiable in patients with congestive cardiomyopathy by positron emission tomography and may be particularly valuable for early detection and characterization of cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601460     DOI: 10.1016/0002-9343(83)91065-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

1.  Abstention from alcohol in dilated cardiomyopathy: complete regression of the clinical disease but persistence of myocardial perfusion defects on exercise thallium-201 tomography.

Authors:  Y Juillière; C Gillet; N Danchin; A Thouvenin; G Karcher; F Paille; A Bertrand; D Barrucand; F Cherrier
Journal:  Eur J Nucl Med       Date:  1990

2.  Perfusion and mechanical analysis with technetium-99m 2-methoxy-isobutyl-isonitrile in a case of dilated cardiomyopathy.

Authors:  T Takeda; H Toyama; N Ishikawa; T Masuoka; R Ajisaka; K Iida; M Satoh; W Jin; T Saitou; T Yamanouchi
Journal:  Ann Nucl Med       Date:  1992-05       Impact factor: 2.668

3.  The right stuff.

Authors:  H W Strauss
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

Review 4.  Cardiac nuclear medicine, present status, future hopes as seen from the view of a cardiologist.

Authors:  P R Lichtlen
Journal:  Eur J Nucl Med       Date:  1988

Review 5.  Clinical applications of assessments of myocardial substrate utilization with positron emission tomography.

Authors:  S R Bergmann
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

Review 6.  Positron emission tomography. Diagnostic and therapeutic implications in human myocardial ischemia.

Authors:  H R Schelbert
Journal:  Int J Card Imaging       Date:  1987

7.  Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.

Authors:  T Nishimura; S Nagata; T Uehara; T Morozumi; Y Ishida; T Nakata; O Iimura; C Kurata; Y Wakabayashi; H Sugihara; K Otsuki; T Wada; Y Koga
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

8.  Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.

Authors:  Y Takeishi; J Chiba; S Abe; I Tonooka; A Komatani; H Tomoike
Journal:  Eur J Nucl Med       Date:  1992

9.  Cardiac positron emission tomography.

Authors:  E M Geltman
Journal:  West J Med       Date:  1985-12

Review 10.  Cardiac nuclear medicine: positron emission tomography in clinical medicine.

Authors:  A Storch-Becker; K P Kaiser; L E Feinendegen
Journal:  Eur J Nucl Med       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.